Corrigendum to "Risk factors for developing mineral bone disease in phenylketonuric patients" [Mol. Genet. Metab. 108 (2013) 149-154]

Affiliations

¹ Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
² Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Metabolic Laboratory, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
³ Unit of Nutrition and Metabolism, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
⁴ Rheumatology Service, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
⁵ Unit of Metabolism, Department of Pediatrics, Hospital de Cruces, Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya, Spain.
⁶ Pediatric Service, Hospital Xeral Cíes, C/Pizarro 2, 36204 Vigo, Spain.
⁷ Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, CIBERER, Health Research Institute of Santiago de Compostela (IDIS), A Choupana, s/n, 15706 Santiago de Compostela, A Coruña, Spain. Electronic address: maria.luz.couce.pico@sergas.es.

Published Erratum

Alicia Mirás et al. Mol Genet Metab. 2015 Mar.

. 2015 Mar;114(3):483.

doi: 10.1016/j.ymgme.2015.01.008. Epub 2015 Feb 11.

¹ Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
² Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Metabolic Laboratory, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
³ Unit of Nutrition and Metabolism, Department of Pediatrics, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
⁴ Rheumatology Service, Hospital Clinico Universitario de Santiago, Travesía da Choupana s/n, 15706 Santiago de Compostela, A Coruña, Spain.
⁵ Unit of Metabolism, Department of Pediatrics, Hospital de Cruces, Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya, Spain.
⁶ Pediatric Service, Hospital Xeral Cíes, C/Pizarro 2, 36204 Vigo, Spain.
⁷ Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, CIBERER, Health Research Institute of Santiago de Compostela (IDIS), A Choupana, s/n, 15706 Santiago de Compostela, A Coruña, Spain. Electronic address: maria.luz.couce.pico@sergas.es.

No abstract available

Erratum for

Risk factors for developing mineral bone disease in phenylketonuric patients.
Mirás A, Bóveda MD, Leis MR, Mera A, Aldámiz-Echevarría L, Fernández-Lorenzo JR, Fraga JM, Couce ML. Mirás A, et al. Mol Genet Metab. 2013 Mar;108(3):149-54. doi: 10.1016/j.ymgme.2012.12.008. Epub 2013 Jan 5. Mol Genet Metab. 2013. PMID: 23352389